Patent Applications for VASCEPA

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

US Patent Applications for VASCEPA

Subscribe to access the full database, or Start Trial
US Patent Application	Patent No.	Title	Patent Filing Date	Patent Application Status	Status Updated
Start Trial	Start Trial	Thrombus/thrombogenesis inhibitors	2004-03-17	Abandoned -- Failure to Respond to an Office Action	2009-02-02
Start Trial	Start Trial	HYPERLIPEMIA THERAPEUTIC AGENT	2004-02-19	Patented Case	2006-03-15
Start Trial	Start Trial	Drug for reducing side effects in ribavirin interferon combination therapy	2005-08-18	Abandoned -- Failure to Respond to an Office Action	2010-10-12
Start Trial	Start Trial	HYPERLIPEMIA THERAPEUTIC AGENT	2005-12-05	Patented Case	2010-07-28
>US Patent Application	>Patent No.	>Title	>Patent Filing Date	>Patent Application Status	>Status Updated

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.